Trial Profile
Combined Administration of Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Analgesia in Posterior Lumbar Spine Surgery - A Prospective Randomized Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 10 Dec 2020 Status changed from recruiting to discontinued.
- 30 Sep 2019 Planned primary completion date changed from 30 Jun 2019 to 31 Dec 2019.
- 04 May 2018 New trial record